The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
BTOG 2018 | Does the UK need a National Optimal Lung Cancer Pathway?
Long waits for and between treatments, leading to worse outcomes for patients, are unacceptable. Improved care pathways are required to streamline the treatment journey. In this interview, Neal Navani, PhD, of University College London Hospitals NHS Foundation Trust, London, UK, discusses the new National Optimal Lung Cancer Pathway (NOLCP). This video was recorded at the British Thoracic Oncology Group (BTOG) Annual Conference 2018, held in Dublin, Ireland.
